279 related articles for article (PubMed ID: 9528804)
1. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
[TBL] [Abstract][Full Text] [Related]
2. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein.
Rauh MJ; Blackmore V; Andrechek ER; Tortorice CG; Daly R; Lai VK; Pawson T; Cardiff RD; Siegel PM; Muller WJ
Mol Cell Biol; 1999 Dec; 19(12):8169-79. PubMed ID: 10567542
[TBL] [Abstract][Full Text] [Related]
3. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.
Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ
Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074
[TBL] [Abstract][Full Text] [Related]
4. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ
Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891
[TBL] [Abstract][Full Text] [Related]
5. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
[TBL] [Abstract][Full Text] [Related]
6. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
Campbell KS; Ogris E; Burke B; Su W; Auger KR; Druker BJ; Schaffhausen BS; Roberts TM; Pallas DC
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6344-8. PubMed ID: 8022784
[TBL] [Abstract][Full Text] [Related]
7. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.
Mullane KP; Ratnofsky M; Culleré X; Schaffhausen B
Mol Cell Biol; 1998 Dec; 18(12):7556-64. PubMed ID: 9819441
[TBL] [Abstract][Full Text] [Related]
8. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
[TBL] [Abstract][Full Text] [Related]
9. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
[TBL] [Abstract][Full Text] [Related]
10. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
[TBL] [Abstract][Full Text] [Related]
11. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
Al Masri A; Gendler SJ
Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
[TBL] [Abstract][Full Text] [Related]
12. Deletion of proline-rich domain in polyomavirus T antigens results in virus partially defective in transformation and tumorigenesis.
Yi X; Freund R
Virology; 1998 Sep; 248(2):420-31. PubMed ID: 9721249
[TBL] [Abstract][Full Text] [Related]
13. Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles.
Schade B; Lam SH; Cernea D; Sanguin-Gendreau V; Cardiff RD; Jung BL; Hallett M; Muller WJ
Cancer Res; 2007 Aug; 67(16):7579-88. PubMed ID: 17699761
[TBL] [Abstract][Full Text] [Related]
14. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.
Gu H; Maeda H; Moon JJ; Lord JD; Yoakim M; Nelson BH; Neel BG
Mol Cell Biol; 2000 Oct; 20(19):7109-20. PubMed ID: 10982827
[TBL] [Abstract][Full Text] [Related]
15. The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members.
Webster MA; Martin-Soudant N; Nepveu A; Cardiff RD; Muller WJ
Oncogene; 1998 Apr; 16(15):1963-72. PubMed ID: 9591780
[TBL] [Abstract][Full Text] [Related]
16. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
Denis D; Rouleau C; Schaffhausen BS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
Walker F; Kato A; Gonez LJ; Hibbs ML; Pouliot N; Levitzki A; Burgess AW
Mol Cell Biol; 1998 Dec; 18(12):7192-204. PubMed ID: 9819406
[TBL] [Abstract][Full Text] [Related]
18. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
19. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding.
Yi X; Peterson J; Freund R
J Virol; 1997 Sep; 71(9):6279-86. PubMed ID: 9261344
[TBL] [Abstract][Full Text] [Related]
20. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
